Aptevo Therapeutics APVO is a clinical-stage pharmaceutical company focused on developing novel therapies targeting cancer indications. In the past week, the company’s stock lost 79.0%. This downside ...

A downtrend has been apparent in Aptevo Therapeutics Inc. (APVO) lately. While the stock has lost 12% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its ...

Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and ...

Aptevo Therapeutics Inc. (APVO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Aptevo Therapeutics (APVO) is a stock that can certainly grab ...

With all of this in mind, we’re going to go over the fresh action encompassing Aptevo Therapeutics Inc (NASDAQ:APVO).

Detailed price information for Aptevo Therapeutics Inc (APVO-Q) from The Globe and Mail including charting and trades.